7. UroLift System for LUTS Given Highest Possible Rating in Updated EAU Guidelines
The European Association of Urology (EAU) has raised the rating of the UroLift system to the highest possible classification, Level 1A, in its recently updated guidelines for male lower urinary tract symptoms (LUTS). NeoTract, Inc., the medical urology company that developed UroLift, also presented clinical data resulting from two multinational studies, the four-year durability results of the L.I.F.T. randomized study and two-year results of the BPH6 randomized study, at the recent EAU Conference in Munich.
